<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD09560000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P60568</UniProt_ID>
  <Seq_Length>153</Seq_Length>
  <Molecule_Weight>17628</Molecule_Weight>
  <KEGG_ID>hsa:3558</KEGG_ID>
  <Orthology_ID>K05429</Orthology_ID>
  <Function_Summary>Produced by T-cells in response to antigenic or mitogenic stimulation, this protein is required for T-cell proliferation and other activities crucial to regulation of the immune response. Can stimulate B-cells, monocytes, lymphokine-activated killer cells, natural killer cells, and glioma cells.</Function_Summary>
  <Pfam_ID>PF00715:IL2</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>1</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>T-cell growth factor</Alias>
      <Alias>IL-2</Alias>
      <Alias>TCGF</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any carbohydrate, any of a group of organic compounds based of the general formula Cx(H2O)y.</Detail>
      <Keyword>Carbohydrate binding</Keyword>
      <Ontology_ID>GO:0030246</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Increases the activity of a kinase, an enzyme which catalyzes of the transfer of a phosphate group, usually from ATP, to a substrate molecule.</Detail>
      <Keyword>Kinase activator activity</Keyword>
      <Ontology_ID>GO:0019209</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with the interleukin-2 receptor.</Detail>
      <Keyword>Interleukin-2 receptor binding</Keyword>
      <Ontology_ID>GO:0005134</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Functions to control the survival, growth, differentiation and effector function of tissues and cells.</Detail>
      <Keyword>Cytokine activity</Keyword>
      <Ontology_ID>GO:0005125</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.</Detail>
      <Keyword>Growth factor activity</Keyword>
      <Ontology_ID>GO:0008083</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with glycosphingolipid, a compound with residues of sphingoid and at least one monosaccharide.</Detail>
      <Keyword>Glycosphingolipid binding</Keyword>
      <Ontology_ID>GO:0043208</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate, or extent of tissue remodeling.</Detail>
      <Keyword>Positive regulation of tissue remodeling</Keyword>
      <Ontology_ID>GO:0034105</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the rate, frequency, or extent of dendritic spine development, the process whose specific outcome is the progression of the dendritic spine over time, from its formation to the mature structure.</Detail>
      <Keyword>Positive regulation of dendritic spine development</Keyword>
      <Ontology_ID>GO:0060999</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate, or extent of interleukin-17 production.</Detail>
      <Keyword>Positive regulation of interleukin-17 production</Keyword>
      <Ontology_ID>GO:0032740</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of isotype switching to IgG isotypes.</Detail>
      <Keyword>Positive regulation of isotype switching to IgG isotypes</Keyword>
      <Ontology_ID>GO:0048304</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of resting T cell proliferation.</Detail>
      <Keyword>Regulation of T cell homeostatic proliferation</Keyword>
      <Ontology_ID>GO:0046013</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.</Detail>
      <Keyword>Negative regulation of protein phosphorylation</Keyword>
      <Ontology_ID>GO:0001933</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the rate or extent of activated T cell proliferation.</Detail>
      <Keyword>Positive regulation of activated T cell proliferation</Keyword>
      <Ontology_ID>GO:0042104</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of differentiation of regulatory T cells.</Detail>
      <Keyword>Positive regulation of regulatory T cell differentiation</Keyword>
      <Ontology_ID>GO:0045591</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of cell growth.</Detail>
      <Keyword>Positive regulation of cell growth</Keyword>
      <Ontology_ID>GO:0030307</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.</Detail>
      <Keyword>Negative regulation of inflammatory response</Keyword>
      <Ontology_ID>GO:0050728</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.</Detail>
      <Keyword>Cell adhesion</Keyword>
      <Ontology_ID>GO:0007155</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the rate or extent of B cell proliferation.</Detail>
      <Keyword>Positive regulation of B cell proliferation</Keyword>
      <Ontology_ID>GO:0030890</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the inflammatory response.</Detail>
      <Keyword>Positive regulation of inflammatory response</Keyword>
      <Ontology_ID>GO:0050729</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which a precursor cell type acquires characteristics of a more mature T-cell. A T cell is a type of lymphocyte whose definin characteristic is the expression of a T cell receptor complex.</Detail>
      <Keyword>T cell differentiation</Keyword>
      <Ontology_ID>GO:0030217</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.</Detail>
      <Keyword>Immune response</Keyword>
      <Ontology_ID>GO:0006955</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate, or extent of B cell apoptosis.</Detail>
      <Keyword>Negative regulation of B cell apoptosis</Keyword>
      <Ontology_ID>GO:0002903</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the introduction of a phosphate group to a tyrosine residue of a Stat5 protein.</Detail>
      <Keyword>Positive regulation of tyrosine phosphorylation of Stat5 protein</Keyword>
      <Ontology_ID>GO:0042523</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Protein involved in adaptive immunity. Vertebrates can develop a broad and almost infinite repertoire of antigen-specific receptors, which allows vertebrates to recognize almost any potential pathogen or toxin and to mount antigen-specific responses to it. Two types of adaptive immunity systems have evolved in vertebrates in order to generate immune receptor diversity. The jawed vertebrates strategy uses the V(D)JC recombination to achieve combinatorial diversity of immunoglobulin-based B cell receptors and T cell receptors. The jawless vertebrate strategy uses the somatic rearrangements of variable leucine-rich cassettes in the variable lymphocyte receptors (VLRs). The hallmarks of an adaptive immune system is the production of antigen-specific recognition receptor by somatic gene rearrangement. The long life of some antigen-primed cytotoxic lymphocytes and plasma cells provide protective memory to prevent reinvasion.</Detail>
      <Keyword>Adaptive immunity</Keyword>
      <Ontology_ID>KW-1064</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of transcription from the RNA polymerase II promoter.</Detail>
      <Keyword>Positive regulation of transcription from RNA polymerase II promoter</Keyword>
      <Ontology_ID>GO:0045944</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of heart contraction.</Detail>
      <Keyword>Negative regulation of heart contraction</Keyword>
      <Ontology_ID>GO:0045822</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the regulated release of immunoglobulins from a cell or group of cells.</Detail>
      <Keyword>Positive regulation of immunoglobulin secretion</Keyword>
      <Ontology_ID>GO:0051024</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Protein involved in immunity, any immune system process that functions in the response of an organism to a potential internal or invasive threat. The vertebrate immune system is formed by the innate immune system (composed of phagocytes, complement, antimicrobial peptides, etc) and by the adaptive immune system which consists of T- and B-lymphocytes.</Detail>
      <Keyword>Immunity</Keyword>
      <Ontology_ID>KW-0391</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that mediates the transfer of information from one cell to another.</Detail>
      <Keyword>Cell-cell signaling</Keyword>
      <Ontology_ID>GO:0007267</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the concentration of calcium ions in the cytosol.</Detail>
      <Keyword>Elevation of cytosolic calcium ion concentration</Keyword>
      <Ontology_ID>GO:0007204</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The change in morphology and behavior of a natural killer cell in response to a cytokine, chemokine, cellular ligand, or soluble factor.</Detail>
      <Keyword>Natural killer cell activation</Keyword>
      <Ontology_ID>GO:0030101</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.</Detail>
      <Keyword>Positive regulation of interferon-gamma production</Keyword>
      <Ontology_ID>GO:0032729</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents or reduces the rate or extent of lymphocyte proliferation.</Detail>
      <Keyword>Negative regulation of lymphocyte proliferation</Keyword>
      <Ontology_ID>GO:0050672</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The initiation of the activity of the inactive enzyme protein kinase C as the result of a series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand.</Detail>
      <Keyword>Activation of protein kinase C activity by G-protein coupled receptor protein signaling pathway</Keyword>
      <Ontology_ID>GO:0007205</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT</Protein_Seq>
    <DNA_Seq>AGTTCCCTATCACTCTCTTTAATCACTACTCACAGTAACCTCAACTCCTGCCACAATGTACAGGATGCAACTCCTGTCTTGCATTGCACTAAGTCTTGCACTTGTCACAAACAGTGCACCTACTTCAAGTTCTACAAAGAAAACACAGCTACAACTGGAGCATTTACTGCTGGATTTACAGATGATTTTGAATGGAATTAATAATTACAAGAATCCCAAACTCACCAGGATGCTCACATTTAAGTTTTACATGCCCAAGAAGGCCACAGAACTGAAACATCTTCAGTGTCTAGAAGAAGAACTCAAACCTCTGGAGGAAGTGCTAAATTTAGCTCAAAGCAAAAACTTTCACTTAAGACCCAGGGACTTAATCAGCAATATCAACGTAATAGTTCTGGAACTAAAGGGATCTGAAACAACATTCATGTGTGAATATGCTGATGAGACAGCAACCATTGTAGAATTTCTGAACAGATGGATTACCTTTTGTCAAAGCATCATCTCAACACTGACTTGATAATTAAGTGCTTCCCACTTAAAACATATCAGGCCTTCTATTTATTTAAATATTTAAATTTTATATTTATTGTTGAATGTATGGTTTGCTACCTATTGTAACTATTATTCTTAATCTTAAAACTATAAATATGGATCTTTTATGATTCTTTTTGTAAGCCCTAGGGGCTCTAAAATGGTTTCACTTATTTATCCCAAAATATTTATTATTATGTTGAATGTTAAATATAGTATCTATGTAGATTGGTTAGTAAAACTATTTAATAAATTTGATAAATATAAAAAAAAAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular space</CellLocal>
      <Ontology_ID>GO:0005615</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular region</CellLocal>
      <Ontology_ID>GO:0005576</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Secreted</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>IL2</Gene_Name>
    <Gene_ID>3558</Gene_ID>
    <Genbank_ACCN>NM_000586</Genbank_ACCN>
    <Protein_ACCN>NP_000577</Protein_ACCN>
    <HGNC_ID>6001</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/3558</Gene_URL>
    <UCSC_ID>uc003ier.3</UCSC_ID>
    <EMBL_ID>ENSG00000109471</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Farmer's Lung</Disease_Name>
      <Disease_Detail>Farmer's Lung</Disease_Detail>
      <Disease_DB>FRM003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/farmers_lung?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemangioendothelioma</Disease_Name>
      <Disease_Detail>Hemangioendothelioma</Disease_Detail>
      <Disease_DB>HMN016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemangioendothelioma?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Chronic Active Epstein-Barr Virus Infection</Disease_Name>
      <Disease_Detail>Chronic Active Epstein-Barr Virus Infection</Disease_Detail>
      <Disease_DB>CHR276</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/chronic_active_epstein_barr_virus_infection?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Renal Cell Carcinoma</Disease_Name>
      <Disease_Detail>Renal Cell Carcinoma</Disease_Detail>
      <Disease_DB>RNL014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/renal_cell_carcinoma?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Kidney Cancer</Disease_Name>
      <Disease_Detail>Kidney Cancer</Disease_Detail>
      <Disease_DB>KDN017</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/kidney_cancer?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Tularemia</Disease_Name>
      <Disease_Detail>Tularemia</Disease_Detail>
      <Disease_DB>TLR001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/tularemia?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Erysipeloid</Disease_Name>
      <Disease_Detail>Erysipeloid</Disease_Detail>
      <Disease_DB>ERY001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/erysipeloid?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Capillary Leak Syndrome</Disease_Name>
      <Disease_Detail>Capillary Leak Syndrome</Disease_Detail>
      <Disease_DB>CPL003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/capillary_leak_syndrome?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Parainfluenza Virus Type 3</Disease_Name>
      <Disease_Detail>Parainfluenza Virus Type 3</Disease_Detail>
      <Disease_DB>PRN029</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/parainfluenza_virus_type_3?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Microscopic Colitis</Disease_Name>
      <Disease_Detail>Microscopic Colitis</Disease_Detail>
      <Disease_DB>MCR191</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/microscopic_colitis?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Giant Cell Myocarditis</Disease_Name>
      <Disease_Detail>Giant Cell Myocarditis</Disease_Detail>
      <Disease_DB>GNT019</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/giant_cell_myocarditis?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Severe Combined Immunodeficiency</Disease_Name>
      <Disease_Detail>Severe Combined Immunodeficiency</Disease_Detail>
      <Disease_DB>SVR004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/severe_combined_immunodeficiency?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Eosinophilic Meningitis</Disease_Name>
      <Disease_Detail>Eosinophilic Meningitis</Disease_Detail>
      <Disease_DB>ESN006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/eosinophilic_meningitis?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Balanoposthitis</Disease_Name>
      <Disease_Detail>Balanoposthitis</Disease_Detail>
      <Disease_DB>BLN009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/balanoposthitis?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>T Cell Deficiency</Disease_Name>
      <Disease_Detail>T Cell Deficiency</Disease_Detail>
      <Disease_DB>TCL003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/t_cell_deficiency?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Periapical Granuloma</Disease_Name>
      <Disease_Detail>Periapical Granuloma</Disease_Detail>
      <Disease_DB>PRP002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/periapical_granuloma?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Limited Scleroderma</Disease_Name>
      <Disease_Detail>Limited Scleroderma</Disease_Detail>
      <Disease_DB>LMT001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/limited_scleroderma?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Mast Cell Neoplasm</Disease_Name>
      <Disease_Detail>Mast Cell Neoplasm</Disease_Detail>
      <Disease_DB>MST004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/mast_cell_neoplasm?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Intervertebral Disc Disease</Disease_Name>
      <Disease_Detail>Intervertebral Disc Disease</Disease_Detail>
      <Disease_DB>INT146</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/intervertebral_disc_disease?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Berylliosis</Disease_Name>
      <Disease_Detail>Berylliosis</Disease_Detail>
      <Disease_DB>BRY001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/berylliosis?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Uremic Pruritus</Disease_Name>
      <Disease_Detail>Uremic Pruritus</Disease_Detail>
      <Disease_DB>URM005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/uremic_pruritus?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Polyradiculoneuropathy</Disease_Name>
      <Disease_Detail>Polyradiculoneuropathy</Disease_Detail>
      <Disease_DB>PLY020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/polyradiculoneuropathy?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Multifocal Motor Neuropathy</Disease_Name>
      <Disease_Detail>Multifocal Motor Neuropathy</Disease_Detail>
      <Disease_DB>MLT075</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/multifocal_motor_neuropathy?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Epithelioid Hemangioendothelioma</Disease_Name>
      <Disease_Detail>Epithelioid Hemangioendothelioma</Disease_Detail>
      <Disease_DB>EPT020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/epithelioid_hemangioendothelioma?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cervicitis</Disease_Name>
      <Disease_Detail>Cervicitis</Disease_Detail>
      <Disease_DB>CRV039</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cervicitis?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Egg Allergy</Disease_Name>
      <Disease_Detail>Egg Allergy</Disease_Detail>
      <Disease_DB>EGG001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/egg_allergy?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Tuberculosis</Disease_Name>
      <Disease_Detail>Tuberculosis</Disease_Detail>
      <Disease_DB>TBR010</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/tuberculosis?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Colitis</Disease_Name>
      <Disease_Detail>Colitis</Disease_Detail>
      <Disease_DB>CLT003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/colitis?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cytomegalovirus Retinitis</Disease_Name>
      <Disease_Detail>Cytomegalovirus Retinitis</Disease_Detail>
      <Disease_DB>CYT005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cytomegalovirus_retinitis?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Trichomoniasis</Disease_Name>
      <Disease_Detail>Trichomoniasis</Disease_Detail>
      <Disease_DB>TRC003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/trichomoniasis?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Severe Combined Immunodeficiency Due to Il2 Deficiency</Disease_Name>
      <Disease_Detail>Severe Combined Immunodeficiency</Disease_Detail>
      <Disease_DB>SVR007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/severe_combined_immunodeficiency_due_to_il2_deficiency?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Oral Tuberculosis</Disease_Name>
      <Disease_Detail>Oral Tuberculosis</Disease_Detail>
      <Disease_DB>ORL003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/oral_tuberculosis?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Burning Mouth Syndrome</Disease_Name>
      <Disease_Detail>Burning Mouth Syndrome</Disease_Detail>
      <Disease_DB>BRN009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/burning_mouth_syndrome?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Human T-Cell Leukemia Virus Type 2</Disease_Name>
      <Disease_Detail>Human T-Cell Leukemia Virus Type 2</Disease_Detail>
      <Disease_DB>HMN022</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/human_t_cell_leukemia_virus_type_2?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Conjunctival Disease</Disease_Name>
      <Disease_Detail>Conjunctival Disease</Disease_Detail>
      <Disease_DB>CNJ012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/conjunctival_disease?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Myocarditis</Disease_Name>
      <Disease_Detail>Myocarditis</Disease_Detail>
      <Disease_DB>MYC008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/myocarditis?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Atopic Keratoconjunctivitis</Disease_Name>
      <Disease_Detail>Atopic Keratoconjunctivitis</Disease_Detail>
      <Disease_DB>ATP013</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/atopic_keratoconjunctivitis?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Leprosy</Disease_Name>
      <Disease_Detail>Leprosy</Disease_Detail>
      <Disease_DB>LPR003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/leprosy?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Vulvovaginal Candidiasis</Disease_Name>
      <Disease_Detail>Vulvovaginal Candidiasis</Disease_Detail>
      <Disease_DB>VLV011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/vulvovaginal_candidiasis?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ulcerative Colitis</Disease_Name>
      <Disease_Detail>Ulcerative Colitis</Disease_Detail>
      <Disease_DB>ULC004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ulcerative_colitis?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Chronic Berylliosis</Disease_Name>
      <Disease_Detail>Chronic Berylliosis</Disease_Detail>
      <Disease_DB>CHR278</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/chronic_berylliosis?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Angiostrongyliasis</Disease_Name>
      <Disease_Detail>Angiostrongyliasis</Disease_Detail>
      <Disease_DB>ANG002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/angiostrongyliasis?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Extramedullary Plasmacytoma</Disease_Name>
      <Disease_Detail>Extramedullary Plasmacytoma</Disease_Detail>
      <Disease_DB>EXT010</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/extramedullary_plasmacytoma?search=IL2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Idiopathic Achalasia</Disease_Name>
      <Disease_Detail>Idiopathic Achalasia</Disease_Detail>
      <Disease_DB>IDP035</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/idiopathic_achalasia?search=IL2#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Structure of a 60 nM Small Molecule Bound to a Hot Spot on IL-2</PDB_Title>
      <PDB_ID>1PY2</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1PY2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Potent small-molecule binding to a dynamic hot spot on IL-2.</PubMed_Title>
      <Author>Thanos, C.D., et al.</Author>
      <Journal>J.Am.Chem.Soc.(2003)125:15280-15281</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/14664558?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>cytokine receptor complex</PDB_Title>
      <PDB_ID>2B5I</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2B5I</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors.</PubMed_Title>
      <Author>Wang, X., et al.</Author>
      <Journal>Science(2005)310:1159-1163</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16293754?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Human Interleukin-2</PDB_Title>
      <PDB_ID>1M4C</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1M4C</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Binding of small molecules to an adaptive  protein-protein interface</PubMed_Title>
      <Author>Arkin, M.A., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2003)100:1603-1608</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12582206?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Human Interleukin-2</PDB_Title>
      <PDB_ID>1M47</PDB_ID>
      <Resolution>1.99</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1M47</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Binding of small molecules to an adaptive  protein-protein interface</PubMed_Title>
      <Author>Arkin, M.A., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2003)100:1603-1608</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12582206?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Human IL-2 Complexed with (R)-N-[2-[1-(Aminoiminomethyl)-3-piperidinyl]-1-oxoethyl]-4-(phenylethynyl)-L-phenylalanine methyl ester</PDB_Title>
      <PDB_ID>1M48</PDB_ID>
      <Resolution>1.95</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1M48</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Binding of small molecules to an adaptive  protein-protein interface</PubMed_Title>
      <Author>Arkin, M.A., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2003)100:1603-1608</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12582206?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of SP4160 Bound to IL-2 V69A</PDB_Title>
      <PDB_ID>1QVN</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1QVN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Hot-spot mimicry of a cytokine receptor by a small molecule.</PubMed_Title>
      <Author>Thanos, C.D., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2006)103:15422-15427</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17032757?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>UNRAVELING THE STRUCTURE OF INTERLEUKIN-2: REPLY</PDB_Title>
      <PDB_ID>3INK</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3INK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Unraveling the structure of IL-2.</PubMed_Title>
      <Author>Bazan, J.F., et al.</Author>
      <Journal>Science(1992)257:410-413</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/1631562?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the heterotrimeric interleukin-2 receptor in complex with interleukin-2</PDB_Title>
      <PDB_ID>2ERJ</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2ERJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the IL-2 signaling complex: Paradigm for a heterotrimeric cytokine receptor.</PubMed_Title>
      <Author>Stauber, D.J., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.Usa(2006)103:2793</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16477002?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure Of Human Interleukin-2 Y31C Covalently Modified At C31 With 3-Mercapto-1-(1,3,4,9-tetrahydro-B-carbolin-2-yl)-propan-1-one</PDB_Title>
      <PDB_ID>1NBP</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1NBP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery and characterization of cooperative ligand binding in the adaptive region of interleukin-2</PubMed_Title>
      <Author>Hyde, J., et al.</Author>
      <Journal>Biochemistry(2003)42:6475-6483</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12767230?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Human Interleukin-2 Y31C Covalently Modified at C31 with (1H-Indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid</PDB_Title>
      <PDB_ID>1M4A</PDB_ID>
      <Resolution>2.18</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1M4A</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Binding of small molecules to an adaptive  protein-protein interface</PubMed_Title>
      <Author>Arkin, M.A., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2003)100:1603-1608</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12582206?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Human Interleukin-2 K43C Covalently Modified at C43 with 2-[2-(2-Cyclohexyl-2-guanidino-acetylamino)-acetylamino]-N-(3-mercapto-propyl)-propionamide</PDB_Title>
      <PDB_ID>1M4B</PDB_ID>
      <Resolution>2.15</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1M4B</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Binding of small molecules to an adaptive  protein-protein interface</PubMed_Title>
      <Author>Arkin, M.A., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2003)100:1603-1608</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12582206?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>structure of interleukin-2 with its alpha receptor</PDB_Title>
      <PDB_ID>1Z92</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Z92</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The structure of interleukin-2 complexed with its alpha receptor.</PubMed_Title>
      <Author>Rickert, M., et al.</Author>
      <Journal>Science(2005)308:1477-1480</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15933202?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Low Micromolar Small Molecule Inhibitor of IL-2</PDB_Title>
      <PDB_ID>1PW6</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1PW6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Potent small-molecule binding to a dynamic hot spot on IL-2.</PubMed_Title>
      <Author>Thanos, C.D., et al.</Author>
      <Journal>J.Am.Chem.Soc.(2003)125:15280-15281</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/14664558?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>IL-2 mutant D10 ternary complex</PDB_Title>
      <PDB_ID>3QAZ</PDB_ID>
      <Resolution>3.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3QAZ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'</PubMed_Title>
      <Author>Levin, A.M., et al.</Author>
      <Journal>Nature(2012)484:529-533</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22446627?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE SOLUTION STRUCTURE OF THE F42A MUTANT OF HUMAN INTERLEUKIN 2</PDB_Title>
      <PDB_ID>1IRL</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1IRL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The solution structure of the F42A mutant of human interleukin 2.</PubMed_Title>
      <Author>Mott, H.R., et al.</Author>
      <Journal>J.Mol.Biol.(1995)247:979-994</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/7723044?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Human Interleukin-2 Complexed with SP-1985</PDB_Title>
      <PDB_ID>1M49</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1M49</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Binding of small molecules to an adaptive  protein-protein interface</PubMed_Title>
      <Author>Arkin, M.A., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2003)100:1603-1608</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12582206?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Interleukin-2 mutant D10</PDB_Title>
      <PDB_ID>3QB1</PDB_ID>
      <Resolution>3.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3QB1</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'</PubMed_Title>
      <Author>Levin, A.M., et al.</Author>
      <Journal>Nature(2012)484:529-533</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22446627?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04151</Pathway_ID>
      <Pathway_Title>PI3K-Akt signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04660</Pathway_ID>
      <Pathway_Title>T cell receptor signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05321</Pathway_ID>
      <Pathway_Title>Inflammatory bowel disease (IBD)</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Immune diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05166</Pathway_ID>
      <Pathway_Title>HTLV-I infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05142</Pathway_ID>
      <Pathway_Title>Chagas disease (American trypanosomiasis)</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05162</Pathway_ID>
      <Pathway_Title>Measles</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04940</Pathway_ID>
      <Pathway_Title>Type I diabetes mellitus</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Endocrine and metabolic diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04630</Pathway_ID>
      <Pathway_Title>Jak-STAT signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04060</Pathway_ID>
      <Pathway_Title>Cytokine-cytokine receptor interaction</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signaling molecules and interaction</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>All alpha proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.b.dj.b.c.j.html</SCOP_URL>
    <CATH_Class>Class 1: Mainly Alpha </CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1m48</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>site,58,Arg;site,62,Phe;site,63,Lys;site,82,Glu;site,92,Leu;site,93,Ala</Site_Detail>
      <Site_Reference>Bowman GR, et al. Proc Natl Acad Sci U S A. 2012 Jul 17;109(29):11681-6.</Site_Reference>
      <Site_Type>Ligand-binding domain (LBD) allosteric</Site_Type>
      <PubMed_ID>22753506</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD09560001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2013-04-23</Create_Date>
</Organism_Record>